D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 132 Citations 66,275 878 World Ranking 923 National Ranking 554
Best female scientists D-index 139 Citations 74,330 1,159 World Ranking 153 National Ranking 101

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Gene

Her primary areas of study are Internal medicine, Breast cancer, Odds ratio, Genome-wide association study and Case-control study. Her work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology. Her Breast cancer research is classified as research in Cancer.

Her Odds ratio research includes themes of Obstetrics, Physiology, Confidence interval and Risk factor. Xiao-Ou Shu has researched Genome-wide association study in several fields, including Genetic association, Bioinformatics and Genetic predisposition. Her Case-control study research incorporates themes from Endometrial cancer, Immunology and Confounding.

Her most cited work include:

  • Large-scale genotyping identifies 41 new loci associated with breast cancer risk (866 citations)
  • Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries (865 citations)
  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (859 citations)

What are the main themes of her work throughout her whole career to date?

Xiao-Ou Shu focuses on Internal medicine, Breast cancer, Cancer, Oncology and Odds ratio. Within one scientific family, Xiao-Ou Shu focuses on topics pertaining to Endocrinology under Internal medicine, and may sometimes address concerns connected to Physiology. Her research in Breast cancer intersects with topics in Single-nucleotide polymorphism, Genome-wide association study, Genotype and Gynecology.

Her study in Cancer is interdisciplinary in nature, drawing from both Gastroenterology, Cancer research and Surgery. Her Oncology research integrates issues from Estrogen receptor, Pancreatic cancer and Pathology. Her Odds ratio study incorporates themes from Pregnancy, Endometrial cancer and Risk factor.

She most often published in these fields:

  • Internal medicine (52.99%)
  • Breast cancer (35.24%)
  • Cancer (30.19%)

What were the highlights of her more recent work (between 2018-2021)?

  • Internal medicine (52.99%)
  • Breast cancer (35.24%)
  • Oncology (27.92%)

In recent papers she was focusing on the following fields of study:

Xiao-Ou Shu mainly investigates Internal medicine, Breast cancer, Oncology, Cancer and Confidence interval. Prospective cohort study, Cohort study, Odds ratio, Lung cancer and Cohort are the primary areas of interest in her Internal medicine study. Her Breast cancer study integrates concerns from other disciplines, such as Cancer research, Genome-wide association study and Gene expression.

Her biological study deals with issues like Genetic association, which deal with fields such as Allele. Her research on Cancer focuses in particular on Colorectal cancer. Her Confidence interval research is multidisciplinary, relying on both Gastroenterology and Logistic regression.

Between 2018 and 2021, her most popular works were:

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (335 citations)
  • An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk. (237 citations)
  • Novel Common Genetic Susceptibility Loci for Colorectal Cancer (68 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

Her main research concerns Internal medicine, Genome-wide association study, Oncology, Breast cancer and Hazard ratio. Her study in Cancer, Odds ratio, Confidence interval, Prospective cohort study and Lung cancer is carried out as part of her studies in Internal medicine. Her Odds ratio research is multidisciplinary, incorporating perspectives in Single-nucleotide polymorphism and Epidemiology.

Her Genome-wide association study study results in a more complete grasp of Genetics. Her Breast cancer study combines topics in areas such as CHEK2, Cancer research and Family history. Her Hazard ratio study combines topics from a wide range of disciplines, such as Cohort study, Young adult, Relative survival, Proportional hazards model and Confounding.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)

1074 Citations

Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)

951 Citations

Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians

Wei Zheng;Dale F. McLerran;Betsy Rolland;Xianglan Zhang.
The New England Journal of Medicine (2011)

827 Citations

Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease

John E. Wagner;Joseph Rosenthal;Joseph Rosenthal;Robert Sweetman;Robert Sweetman;Xiao Ou Shu;Xiao Ou Shu.
Blood (1996)

790 Citations

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Nature (2017)

691 Citations

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.

Anubha Mahajan;Min Jin Go;Weihua Zhang;Jennifer E. Below.
Nature Genetics (2014)

670 Citations

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer

Laufey Amundadottir;Peter Kraft;Rachael Z. Stolzenberg-Solomon;Charles S. Fuchs.
Nature Genetics (2009)

634 Citations

Soyfood Intake during Adolescence and Subsequent Risk of Breast Cancer among Chinese Women

Xiao Ou Shu;Fan Jin;Qi Dai;Wanqing Wen.
Cancer Epidemiology, Biomarkers & Prevention (2001)

589 Citations

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1

Wei Zheng;Jirong Long;Yu Tang Gao;Chun Li.
Nature Genetics (2009)

579 Citations

Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians

Yoon Shin Cho;Chien Hsiun Chen;Chien Hsiun Chen;Cheng Hu;Jirong Long.
Nature Genetics (2012)

575 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Xiao-Ou Shu

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 377

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 278

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 221

Stephen J. Chanock

Stephen J. Chanock

National Institutes of Health

Publications: 220

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 215

Walter C. Willett

Walter C. Willett

Harvard University

Publications: 214

Douglas F. Easton

Douglas F. Easton

University of Cambridge

Publications: 192

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 191

Peter Kraft

Peter Kraft

Harvard University

Publications: 178

Hermann Brenner

Hermann Brenner

German Cancer Research Center

Publications: 178

Frank B. Hu

Frank B. Hu

Harvard University

Publications: 176

Melissa C. Southey

Melissa C. Southey

Cancer Council Victoria

Publications: 174

Esther M. John

Esther M. John

Stanford University

Publications: 173

Susan E. Hankinson

Susan E. Hankinson

University of Massachusetts Amherst

Publications: 173

Mark I. McCarthy

Mark I. McCarthy

University of Oxford

Publications: 165

Christopher A. Haiman

Christopher A. Haiman

University of Southern California

Publications: 165

Trending Scientists

Miguel Nussbaum

Miguel Nussbaum

Pontificia Universidad Católica de Chile

Sumit Agarwal

Sumit Agarwal

National University of Singapore

Thomas Martinetz

Thomas Martinetz

University of Lübeck

Huiyu Zhou

Huiyu Zhou

University of Leicester

Urs P. Wild

Urs P. Wild

École Polytechnique Fédérale de Lausanne

W. Wallace Cleland

W. Wallace Cleland

University of Wisconsin–Madison

Maher F. El-Kady

Maher F. El-Kady

University of California, Los Angeles

Tim Diekötter

Tim Diekötter

Kiel University

Robert E. Paull

Robert E. Paull

University of Hawaii at Manoa

John C. Roder

John C. Roder

University of Toronto

Jacques U. Baenziger

Jacques U. Baenziger

Washington University in St. Louis

Jaap Visser

Jaap Visser

Utrecht University

Margaret A. McManus

Margaret A. McManus

University of Hawaii System

Stephen V. David

Stephen V. David

Oregon Health & Science University

Michel Eichelbaum

Michel Eichelbaum

University of Tübingen

Namiki Izumi

Namiki Izumi

Musashino Red Cross Hospital

Something went wrong. Please try again later.